Ken Griffin’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
Other funds holding VRDN
KCM
Ken Griffin's VRDN Position: Q3 2026 in Review
Ken Griffin increased its Viridian Therapeutics (VRDN) stake by 4,459% in Q3 2026, buying an estimated $39.3M and bringing the position to 1,882,977 shares worth $38.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1805.
Ken Griffin first reported a position in VRDN in Q4 2015 and has held it in 33 quarters since. The position peaked at $45.3M in Q1 2026. 235 funds tracked by Wall St. Rank hold VRDN as of Q3 2026.
- Ken Griffin held 1,882,977 shares of Viridian Therapeutics worth $38.8M as of Q3 2026.
- Ken Griffin bought 1,841,674 Viridian Therapeutics shares in Q3 2026, an estimated $39.3M.
- Viridian Therapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #1805 holding.
- Ken Griffin first reported a position in Viridian Therapeutics in Q4 2015 and has held it in 33 quarters since.
- Ken Griffin's Viridian Therapeutics position peaked at $45.3M in Q1 2026.
- 235 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.